Dermatomycoses Market Poised for Robust Growth Through 2035 Amid Rising Fungal Infections
Global dermatomycoses market expected to grow significantly through 2035, driven by rising fungal infections and immunocompromised populations. Key players include Novartis, Bayer, and Sun Pharma.
NVSBAYRYTEVAGALDYcombination therapiesdermatomycoses